coming back to life ?

Maybe time to top up on PHC ?

ERX.. get in now, its going to explode

Soul, hope you got in, todays RNS should be the 1st of many, I am noy joking when I say this should surpass 5 during the next couple of years.

Plant Health Care PLC
13 November 2006


Plant Health Care announces exclusive supply agreement with Tate & Lyle
and receives its largest order in Company history

Plant Health Care plc, the leading provider of natural products to the
agriculture and landscaping industries is pleased to announce that it has
secured from Tate & Lyle an exclusive agreement for the use of a by-product of
Tate & Lyle's European molasses fermentation process in North America and
Mexico. This forms the base for Plant Heath Care's non GMO certified organic
fertiliser, Organic Plant Food ('OPF').

Plant Heath Care also announces its first US distribution agreement for OPF with
ADG LLC, a California based agricultural distribution company. The agreement
specifies an opening order for over $1.0 million, the single largest order in
the company's history, for immediate delivery. ADG is a newly formed
distribution company owned by David Griffin, a principal in Salinas based
Shamrock Seeds.

OPF is one of only a very few organic plant based fertilisers in the world that
contains a high nitrogen content, making it a real alternative to the more
traditional animal fertilisers. Importantly for the farming community, the OPF
formulation contains almost 100% more nitrogen than the current plant-based
products on the market, which the company believes will allow the yield of
organic crops to approach that of conventional crops. The Board believes that
OPF will offer the lowest price per unit of nitrogen for any liquid organic
product currently on the market.

This distribution agreement marks the start of PHC's strategy to capture a major
share of the rapidly growing US organic agricultural market. OPF has already
seen steady growth in demand in Europe over the past two years, and the Board is
confident of a similar success in North America. Not only does the North
American market boast one of the largest vegetable industries for organic crops
in the world, but, as a result of the recent E.Coli outbreak in the US, there is
an enormous demand for non-animal based fertilisers.


John Brady, CEO of Plant Health Care, commented, 'We are delighted to sign our
first US distribution agreement for OPF and receive the largest order in the
company's history. It is a great opportunity for Plant Health Care to become one
of the dominant players in the organic fertiliser market which is worth around
$7million to $8 million a year in California alone. We are confident that OPF
can gain a major market share as it offers the farming community a safe
alternative, whilst fulfilling all their requirements and at a low cost.

'We are already in discussions with a number of other distributors in the US,
Canada and Mexico'

Should be more good news to follow, looking very positive on all fronts.
Myconate,pretect,OPF,
I also like the sound of the new all natural soil sterilent to replace the synthetic
methyl bromide (nice)
PHC is going places ......fast

Rising nicely: PHC Bid: 170p Offer: 174p Change: 27

And still not much notice being taken, sudden surge might suggest more Myconate results and maybe a deal on the horizon. I sold a few a short while back as needed funds but may consider adding again soon as this looks ready to fly.
Last time sp increased, company issued statement, what will happen this time, if they say no reason that they know of the sp may fall and prevent a buying opportunity, if its a deal watch this sp race ahead. Still believe 5 possible.

More Myconate test results due in January, which if positive will help with a deal, and 5 more of a probable than a possible.

Hello everyone. What do people think of yesterday's results?

A tad disapointing , we were all used to knock out results it seems , but still positve over all.
Myconate works even on already high yeilding fields it seems , I believe a partnering deal is just around the corner.

you could say that!!!!

I didn't think it would be the very next day, but i'm not complaining.

I find it strange that shares mag haven't mentioned PHC since the deal.
Wonder why.

All good news this morning, final results sales up, successful harpins trial, and in supply talks with four companies for myconate and harpins technology
Off we go again!!!!!

Yep were off!!!!!!

With the recent news and the RSI starting to look top heavy, any pullback would be a good time to top up as further deals could come thick and fast (imo)

More excellent trial results.

Plant Health Care PLC
27 June 2007


Embargoed until 7AM, 27 June 2007


Plant Health Care plc
Myconate(R) produces outstanding yield gains in wheat.


Plant Health Care (AIM: PHC.L), a leading provider of natural products for
plants and soil, is pleased to report the first independent results of its
Myconate(R) testing programmes in wheat. Following impressive results in many
and varied crops over the past several years, the results of these trials now
demonstrate the effectiveness of Myconate(R) in a new class of crops - the small
cereal grains. The Company now has compelling evidence of yield stimulation in
the two most important representatives of this class: wheat and sorghum.

During the 2006/2007 season, Myconate(R) was evaluated in three separate
independent wheat trials in Mexico; two in Baja and one in Sonora. These trials
were conducted by local farmers and distributed across a wide range of soil and
climate conditions for this crop.

In the Baja trials, the yield increases at the two locations were 21% and 16%;
this resulted in increased income for the grower of US$385 per hectare and
US$326 per hectare respectively. In these cases the trials involved large plot
sizes of 4 hectares (10 acres) so the response has been proven on growers farms
in a full commercial setting.

In Sonora, the trials were established to determine the effect of seed rate and
Myconate coating. In this test 20% less seed was planted in the Myconate treated
fields. The yield from both the control field and the Myconate reduced seed
fields were essentially identical (approximately a 23% yield increase on the
Myconate treated field when adjusted for seed rate) and the protein content of
the Myconate(R) treated wheat was increased by 8.5%. As a result, the increased
income to the grower for the higher yield and higher protein content would be
around US$600 per hectare.

Further results of our cereal testing including more wheat, sorghum and barley
trials are expected as the year progresses.

John Brady, CEO of Plant Health Care commented on the results, 'Once again
Myconate has proven its ability to consistently deliver improved yields in a
variety of crops and under differing soil and climatic conditions. We are
especially pleased to now have large scale tests results on the important cereal
grain crops which number in excess of 300 million acres in the North America,
Europe, South America and Southern Africa regions. All of this coincides with
planned timing for further Myconate supply agreements.'

Myconate background
Through the stimulation of endogenous mycorrhizal fungi, PHC's novel Myconate
technology helps crops to develop larger effective rooting volume. Myconate
works by triggering the germination and growth of beneficial micro-organisms
called mycorrhizal fungi which colonize the roots of crop plants. With more
mycorrhizal fungi at work, each plant can draw more nutrients and moisture out
of the soil. More nutrients make for healthier plants, and significantly
greater overall yields. The Board believes Myconate could be the key to
changing the face of farming. The safety and ease of application of Myconate
means that management practices need not be over-hauled. The procedure is a
straightforward blending process, either tank mixing the Myconate with the
fertilizer during planting, or applying the Myconate to the seed before
planting.


For further information please contact:

Plant Heath Care plc Tavistock Communications
John Brady, Chief Executive Jeremy Carey / Simon Compton
Tel: 001 603 525 3702 Tel: 020 7920 3150

Evolution Securities Limited
Tim Worlledge / Tim Redfern
Tel: 020 7071 4312



This information is provided by RNS
The company news service from the London Stock Exchange
ND
MSCUNSWRBBRNUAR

Plant Health Care PLC
24 September 2007

Embargoed until 7.00 24 September 2007



PLANT HEALTH CARE PLC

('Plant Health Care' or 'the Company')


Myconate Field Trial Update


- Significant yield improvement demonstrated on a variety of crops -


Plant Health Care (AIM: PHC.L), a leading provider of natural products for
plants and soil, is pleased to report the success of recent Myconate tests. The
trials, which were all undertaken in the US, are part of the extensive
development programme underway and further reinforce the commercial potential of
Myconate.

When applied to carrots in furrow application at seeding, Myconate produced a
resultant yield improvement in excess of 30% in two separate trials. Both trials
were carried out independently by a major Wisconsin vegetable grower.

Celery trials in Wisconsin demonstrated a 14% harvestable yield increase when
Myconate was applied as a pre-plant, transplant spray. Against the control,
tests showed a 12% increase in total weight and 12% increase in top weight. A
13% yield increase was achieved in trials on onions and, as with celery,
application was by pre-plant, transplant spray. Additionally, a 13% increase in
bulb weight and 11% increase in diameter were recorded.

The results of Myconate trials on grain and straw in winter wheat, tested using
a variety of applications and produced particularly pleasing yield improvements.
When applied as a seed treatment yield increased as much as 5.4% and when
applied as a ground spray the improvement was up to 7.4%. Additionally,
Myconate's application as both a seed treatment and a ground spray delivered
yield increases of up to 9.4%.


Commenting on the trials, John Brady, Chief Executive of Plant Health Care,
said:

'The increase in yields on grain and straw in severe winter conditions are very
pleasing and the results of these tests are compelling, confirming Myconate's
efficacy through a number of applications. The results achieved highlight the
opportunity Myconate presents on a broad range of crops and vegetables. We are
committed to delivering shareholder value through the commercialisation of our
natural technologies and the ongoing development and marketing of Myconate and
Harpin is central to our strategy.'


-Ends-

Plant Health Care PLC
27 September 2007


Embargoed until 0700, 27 September 2007



PLANT HEALTH CARE PLC


Plant Health Care plc ('the Company' or 'Plant Health Care')


5 Million Equity Placing


Plant Health Care plc, the provider of natural products for plant and soil care,
announces that it has raised 4,993,240 (before expenses) by way of a placing of
2,098,000 new ordinary shares at a price of 238 pence per share ('Placing
Shares'). The Placing Shares have been placed with existing shareholders by
Evolution Securities, the Company's Nominated Adviser and broker.

As stated in the Company's interim results released on 24 September 2007, the
Company currently has net cash balances of approximately US$2.0 million as well
as credit facilities in place adequate for its current needs. However, following
discussions with a number of the Company's major shareholders, the Board has
decided that it would be appropriate to take the opportunity to strengthen its
balance sheet and to provide additional resources to accelerate the momentum
which has been achieved as regards the commercialisation of Myconate and Harpin.

The placing is conditional only upon Admission of the Placing Shares to AIM.
Application will be made for the Placing Shares, which rank pari passu with the
existing issued trading shares, to be admitted to trading on AIM and dealings
are expected to commence on Tuesday, 2 October 2007.

John Brady, Chief Executive, commented:

'We are very pleased with the progress we have made towards the
commercialisation of Myconate and Harpin; these additional funds enable us to
invest in the resources necessary to accelerate development'.

He added: 'We are very appreciative of the support given by our shareholders'.

Always a good sign.

Plant Health Care PLC
22 October 2007


TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached (ii):

PLANT HEALTH CARE plc

2. Reason for the notification (please state Yes/No): ( )

An acquisition or disposal of voting rights: (NO)

An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached: (NO)

An event changing the breakdown of voting rights: (NO)
Other (please specify): (YES - Issued Share Capital Adjustment)

3. Full name of person(s) subject to the notification obligation (iii):

Gartmore Investment Limited

4. Full name of shareholder(s) (if different from 3.) (iv):

See attached schedule

5. Date of the transaction (and date on which the threshold is crossed or
reached if different) (v):

28/09/2007

6. Date on which issuer notified:

01/10/2007

7. Threshold(s) that is/are crossed or reached:
9%

8. Notified details:

A: Voting rights attached to shares

Class/type of shares if Situation previous to the Triggering transaction (vi)
possible using the ISIN
CODE
Number of Number of
shares voting Rights
(viii)

GB00B01JC540 3,415,820 3,415,820

Resulting situation after the triggering transaction (vii)
Class/type of Number of Number of voting rights (ix) % of voting rights
shares if shares
possible using
the ISIN CODE
Direct (x) Indirect (xi) Direct Indirect
GB00B01JC540 3,983,820 3,983,820 9.470%

B: Financial Instruments

Resulting situation after the triggering transaction (xii)
Type of Expiration Exercise/ Number of voting rights that may % of
financial Date Conversion be acquired if the instrument is voting
instrument (xiii) Period/Date exercised/ converted. rights
(xiv)

Total (A+B)

Number of % of voting
voting rights rights

3,983,820 9.470%

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments
are effectively held, if applicable (xv):

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

All shares are held indirectly. All figures are based on the company's issued
share capital of 42,069,375 as provided by Exshare.